Board of Directors
/
Kasim Kutay
Disease areas
Science & technology
Partnering & innovation
Sustainable business
Careers
About us
Our products
Investors
News & media
Patient help
Contact us
Chief executive officer of Novo Holdings A/S.
Member of the boards of Novozymes A/S and Evotec SE.
Member of the Life Sciences Advisory Board of Gimv NV.
Managing director, co-head of Europe and member of the Global Management Committee of Moelis & Co., 2009-2016.
Managing director and head of Financial Solutions Group of SUN Group, 2007-2009.
Member of the Board of Governors (2006-2011) and the Investment Committee (2011-2016) of the School of Oriental and African Studies (SOAS).
Member of the Board of Trustees of Northwick Park Institute for Medical Research, 2005-2016.
Positions at Morgan Stanley, including chair of the European Healthcare Group, 1989-2007.
Not considered independent under the Danish Recommendations on Corporate Governance.
Member of the Board of Directors since March 2017. Most recently elected in 2022 for a term of one year.
Member of the Nomination Committee since March 2017.
Member of the Research & Development Committee since March 2020.
Global corporate leadership
Healthcare and pharma industry
Finance & accounting
Business development, M&A and external innovation sourcing
Human capital management
1987: MSc in Economics, the London School of Economics, UK.
1987: BSc in Economics, the London School of Economics, UK.
UK national, born 1965. Male.